Gene: PRKAG1
Official Full Name: protein kinase AMP-activated non-catalytic subunit gamma 1provided by HGNC
Gene Summary: The protein encoded by this gene is a regulatory subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This subunit is one of the gamma regulatory subunits of AMPK. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08408 | PRKAG1 Knockout cell line (HeLa) | Human | PRKAG1 | 1:3~1:6 | Negative | Online Inquiry |
KO08409 | PRKAG1 Knockout cell line (HCT 116) | Human | PRKAG1 | 1:2~1:4 | Negative | Online Inquiry |
KO08410 | PRKAG1 Knockout cell line (HEK293) | Human | PRKAG1 | 1:3~1:6 | Negative | Online Inquiry |
KO08411 | PRKAG1 Knockout cell line (A549) | Human | PRKAG1 | 1:3~1:4 | Negative | Online Inquiry |
PRKAG1 Gene Knockout Cell Lines represent a pivotal tool in molecular biology and genetic research, specifically designed to elucidate the role of the PRKAG1 gene in cellular metabolism and signaling pathways. These genetically modified cell lines are engineered through CRISPR/Cas9 technology, effectively resulting in the selective disruption of the PRKAG1 gene, which encodes a subunit of AMP-activated protein kinase (AMPK). By knocking out PRKAG1, researchers can investigate the consequences on energy homeostasis, cellular growth, and metabolic regulation.
The primary mechanism of action involves the inability of cells to produce the PRKAG1 protein, leading to altered AMPK activity, which plays a vital role in the response to energy stress. This alteration allows scientists to explore critical pathways linked to metabolic diseases, cancer progression, and aging. PRKAG1 Gene Knockout Cell Lines have significant implications in both basic and applied research, enabling the study of pharmacological interventions aimed at modulating AMPK activity for therapeutic purposes.
Comparatively, these cell lines offer unique advantages over other genetic manipulation techniques, such as transient transfection or RNA interference, as they provide stable, long-term expression profiles essential for distinguishing phenotypic changes. The robustness of this knockout model allows researchers to attain reproducibility and reliability in their experimental outcomes, qualities that are particularly useful in preclinical studies.
For researchers and clinicians engaged in metabolic research, cancer biology, or therapeutic drug development, PRKAG1 Gene Knockout Cell Lines are invaluable. They not only facilitate an in-depth understanding of PRKAG1's biological function but also provide a platform for testing new therapeutic strategies targeting metabolic diseases and developing AMPK modulators.
At our company, we specialize in providing high-quality genetic tools for biomedical research, ensuring that our products, including the PRKAG1 Gene Knockout Cell Lines, are produced under rigorous quality control standards and backed by a commitment to advancing scientific knowledge. Our expertise in the field guarantees that you are equipped with reliable tools essential for your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.